Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-01 Sale | 2024-03-05 5:08 pm | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 46,534 | $30.05 | $1,398,347 | 6,545,479 (Indirect) | View |
| 2024-02-26 Sale | 2024-02-28 7:15 pm | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 807,838 | $24.3 | $19,626,903 | 864,487 (Indirect) | View |
| 2024-02-21 Sale | 2024-02-23 6:59 pm | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 500,789 | $22.64 | $11,339,780 | 920,843 (Indirect) | View |
| 2024-02-15 Sale | 2024-02-20 6:36 pm | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 510,152 | $23.26 | $11,867,292 | 9,359,331 (Indirect) | View |
| 2022-12-12 Purchase | 2022-12-14 4:56 pm | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 934,581 | $10.7 | $10,000,017 | 9,869,483 (Indirect) | View |
| 2021-09-27 Sale | 2021-09-29 7:16 pm | Generation Bio Co. | GBIO | Rhodes Jason P Director | 81,088 | $25.4 | $2,059,519 | 8,279,484 (Indirect) | View |
| 2021-09-22 Sale | 2021-09-24 9:02 pm | Generation Bio Co. | GBIO | Rhodes Jason P Director | 134,998 | $26.02 | $3,511,993 | 8,279,633 (Indirect) | View |
| 2021-06-24 Sale | 2021-06-28 4:57 pm | Generation Bio Co. | GBIO | Rhodes Jason P Director | 31,008 | $25.85 | $801,618 | 9,379,484 (Indirect) | View |
| 2021-06-21 Sale | 2021-06-23 8:27 pm | Generation Bio Co. | GBIO | Rhodes Jason P Director | 185,078 | $25.05 | $4,635,967 | 9,379,542 (Indirect) | View |
| 2021-04-12 Sale | 2021-04-14 8:20 pm | Generation Bio Co. | GBIO | Rhodes Jason P Director | 140,682 | $25.92 | $3,646,968 | 10,479,484 (Indirect) | View |
| 2021-04-07 Sale | 2021-04-09 8:53 pm | Generation Bio Co. | GBIO | Rhodes Jason P Director | 127,095 | $28.2 | $3,583,860 | 10,620,166 (Indirect) | View |
| 2021-01-26 Sale | 2021-01-28 5:08 pm | Replimune Group Inc. | REPL | Rhodes Jason P Director | 5,558 | $46.14 | $256,446 | 3,228,912 (Indirect) | View |
| 2020-12-18 Sale | 2020-12-22 4:38 pm | Replimune Group Inc. | REPL | Rhodes Jason P Director | 4,319 | $41.95 | $181,182 | 19,285 (Indirect) | View |
| 2020-12-15 Sale | 2020-12-17 6:21 pm | Replimune Group Inc. | REPL | Rhodes Jason P Director | 65,029 | $42.28 | $2,749,721 | 19,550 (Indirect) | View |
| 2020-12-10 Sale | 2020-12-14 7:20 pm | Replimune Group Inc. | REPL | Rhodes Jason P Director | 103,686 | $43.35 | $4,494,442 | 23,481 (Indirect) | View |
| 2020-12-07 Sale | 2020-12-09 7:54 pm | Replimune Group Inc. | REPL | Rhodes Jason P Director | 217,362 | $45.92 | $9,981,231 | 29,748 (Indirect) | View |
| 2019-11-18 Purchase | 2019-11-20 5:50 pm | Replimune Group Inc. | REPL | Rhodes Jason P Director | 1,100,000 | $13.61 | $14,971,000 | 4,934,687 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-08 Option Award | 2023-06-12 4:15 pm | N/A 2033-06-07 | Generation Bio Co. | GBIO | Rhodes Jason P Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-24 Option Award | 2023-05-25 6:38 pm | N/A 2033-05-23 | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 24,900 | $0 | 24,900 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 4:05 pm | N/A 2032-06-08 | Generation Bio Co. | GBIO | Rhodes Jason P Director | 19,200 | $0 | 19,200 (Direct) | View |
| 2022-06-03 Option Award | 2022-06-06 6:42 pm | N/A 2032-06-02 | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 19,596 | $0 | 19,596 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-05 4:13 pm | N/A 2032-04-01 | Replimune Group Inc. | REPL | Rhodes Jason P Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2021-10-04 Option Award | 2021-10-06 4:15 pm | N/A 2031-10-03 | Gemini Therapeutics Inc. | GMTX | Rhodes Jason P Director 10% Owner | 17,245 | $0 | 17,245 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-11 4:14 pm | N/A 2031-06-08 | Generation Bio Co. | GBIO | Rhodes Jason P Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-27 8:38 pm | N/A 2031-05-25 | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 19,596 | $0 | 19,596 (Direct) | View |
| 2021-04-01 Option Award | 2021-04-05 8:16 pm | N/A 2031-04-01 | Replimune Group Inc. | REPL | Rhodes Jason P Director | 16,500 | $0 | 16,500 (Direct) | View |
Ownership | 2021-02-11 1:29 pm | N/A N/A | Gemini Therapeutics Inc. | GMTX | Rhodes Jason P Director | 0 | $0 | 5,254,365 (Indirect) | View |
| 2020-09-21 Conversion | 2020-09-23 7:00 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 32,974,690 | $0 | 1,608,785 (Indirect) | View |
Ownership | 2020-09-16 8:48 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director 10% Owner | 0 | $0 | 9,748,915 (Indirect) | View |
| 2020-06-16 Conversion | 2020-06-18 5:28 pm | N/A N/A | Generation Bio Co. | GBIO | Rhodes Jason P Director | 25,093,735 | $0 | 12,630,758 (Indirect) | View |
| 2020-06-11 Option Award | 2020-06-15 5:28 pm | N/A 2030-06-10 | Generation Bio Co. | GBIO | Rhodes Jason P Director | 52,000 | $0 | 52,000 (Direct) | View |
Ownership | 2020-06-11 8:45 pm | N/A N/A | Generation Bio Co. | GBIO | Rhodes Jason P Director | 0 | $0 | 12,630,758 (Indirect) | View |
| 2020-04-01 Option Award | 2020-04-02 4:32 pm | N/A 2030-04-01 | Replimune Group Inc. | REPL | Rhodes Jason P Director | 16,500 | $0 | 16,500 (Direct) | View |